Nifty
:
15937.15
Sensex
:
53197.96
-303.15 (-1.87%)
-1010.57 (-1.86%)
Nifty
Sensex
:
:
15937.15
53197.96
-303.15 (-1.87%)
-1010.57 (-1.86%)

Kilitch Drugs (India) Ltd.

Pharmaceuticals & Drugs

Rating :
51/99

BSE: 524500 | NSE: KILITCH

NSE BSE
160.05
18-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  165.30
  •  167.95
  •  157.25
  •  165.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  8370
  •  13.55
  •  275.10
  •  141.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 257.40
  • 49.06
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 259.70
  • N/A
  • 1.78

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 68.25%
  • 0.64%
  • 27.59%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 3.52%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -4.44
  • 19.05
  • -6.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -8.29
  • -
  • -2.48

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -26.23
  • -
  • -1.41

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.67
  • 49.83
  • 55.54

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.17
  • 1.62
  • 1.65

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.61
  • 10.22
  • 28.58

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Mar 21
Mar 20
Var%
Net Sales
34.43
20.33
69.36%
23.57
18.07
30.44%
19.63
10.19
92.64%
19.93
11.62
71.51%
Expenses
33.67
17.31
94.51%
19.91
15.12
31.68%
18.72
11.30
65.66%
19.60
13.93
40.70%
EBITDA
0.76
3.02
-74.83%
3.66
2.96
23.65%
0.90
-1.11
-
0.33
-2.30
-
EBIDTM
2.21%
14.85%
15.52%
16.36%
4.60%
-10.92%
1.65%
-19.83%
Other Income
1.31
0.37
254.05%
0.17
0.42
-59.52%
1.05
0.37
183.78%
1.51
1.47
2.72%
Interest
0.24
0.12
100.00%
0.12
0.18
-33.33%
0.13
0.29
-55.17%
0.16
0.23
-30.43%
Depreciation
0.20
0.50
-60.00%
0.70
0.50
40.00%
0.44
0.49
-10.20%
0.50
0.52
-3.85%
PBT
1.64
2.76
-40.58%
3.00
2.71
10.70%
1.39
-1.52
-
1.17
-1.59
-
Tax
1.02
0.58
75.86%
0.42
0.50
-16.00%
0.67
-0.19
-
0.46
-0.34
-
PAT
0.61
2.18
-72.02%
2.58
2.21
16.74%
0.72
-1.33
-
0.71
-1.25
-
PATM
1.78%
10.74%
10.95%
12.22%
3.67%
-13.08%
3.55%
-10.72%
EPS
0.72
1.43
-49.65%
1.39
1.35
2.96%
0.76
-0.86
-
0.46
-0.81
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Net Sales
97.56
68.52
53.32
82.49
51.01
28.65
20.99
19.03
107.96
146.30
142.66
Net Sales Growth
62.03%
28.51%
-35.36%
61.71%
78.05%
36.49%
10.30%
-82.37%
-26.21%
2.55%
 
Cost Of Goods Sold
56.37
37.31
29.09
48.17
26.00
11.25
8.73
7.02
71.19
100.27
98.28
Gross Profit
41.19
31.22
24.23
34.32
25.01
17.39
12.25
12.01
36.78
46.03
44.38
GP Margin
42.22%
45.56%
45.44%
41.61%
49.03%
60.70%
58.36%
63.11%
34.07%
31.46%
31.11%
Total Expenditure
91.90
63.21
53.33
76.47
45.71
29.20
25.29
20.79
95.34
124.23
118.99
Power & Fuel Cost
-
1.63
1.68
1.48
1.15
1.10
0.97
0.82
6.35
6.56
4.82
% Of Sales
-
2.38%
3.15%
1.79%
2.25%
3.84%
4.62%
4.31%
5.88%
4.48%
3.38%
Employee Cost
-
5.24
5.69
5.28
4.30
3.38
3.47
3.13
6.44
5.62
4.10
% Of Sales
-
7.65%
10.67%
6.40%
8.43%
11.80%
16.53%
16.45%
5.97%
3.84%
2.87%
Manufacturing Exp.
-
3.65
3.55
2.88
2.18
2.73
2.68
1.66
5.98
7.60
7.38
% Of Sales
-
5.33%
6.66%
3.49%
4.27%
9.53%
12.77%
8.72%
5.54%
5.19%
5.17%
General & Admin Exp.
-
5.71
6.32
4.78
3.27
2.80
2.71
2.52
2.04
1.88
1.92
% Of Sales
-
8.33%
11.85%
5.79%
6.41%
9.77%
12.91%
13.24%
1.89%
1.29%
1.35%
Selling & Distn. Exp.
-
7.22
6.20
8.64
5.22
4.71
3.46
2.00
2.02
1.47
1.57
% Of Sales
-
10.54%
11.63%
10.47%
10.23%
16.44%
16.48%
10.51%
1.87%
1.00%
1.10%
Miscellaneous Exp.
-
2.44
0.80
5.24
3.59
3.21
3.27
3.64
1.32
0.83
1.57
% Of Sales
-
3.56%
1.50%
6.35%
7.04%
11.20%
15.58%
19.13%
1.22%
0.57%
0.64%
EBITDA
5.65
5.31
-0.01
6.02
5.30
-0.55
-4.30
-1.76
12.62
22.07
23.67
EBITDA Margin
5.79%
7.75%
-0.02%
7.30%
10.39%
-1.92%
-20.49%
-9.25%
11.69%
15.09%
16.59%
Other Income
4.04
2.67
4.55
5.26
3.27
1.14
2.78
2.72
1.06
0.17
0.48
Interest
0.65
0.88
0.94
0.65
0.42
0.16
0.06
0.05
2.96
3.54
4.53
Depreciation
1.84
1.99
2.00
2.05
2.04
9.76
10.05
1.85
4.87
5.59
6.07
PBT
7.20
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
5.84
13.12
13.55
Tax
2.57
1.35
0.77
4.76
0.96
-0.43
-0.44
-0.66
21.05
2.63
2.81
Tax Rate
35.69%
26.37%
47.83%
55.41%
15.71%
4.61%
3.78%
69.47%
21.62%
20.05%
20.74%
PAT
4.62
3.67
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.87
10.56
10.74
PAT before Minority Interest
5.17
3.77
0.84
3.83
5.15
-8.89
-11.19
-0.29
76.31
10.49
10.74
Minority Interest
0.55
-0.10
0.00
0.00
0.00
0.00
0.00
0.00
0.56
0.07
0.00
PAT Margin
4.74%
5.36%
1.58%
4.64%
10.10%
-31.03%
-53.31%
-1.52%
71.20%
7.22%
7.53%
PAT Growth
155.25%
336.90%
-78.07%
-25.63%
-
-
-
-
627.94%
-1.68%
 
EPS
2.96
2.35
0.54
2.46
3.30
-5.70
-7.17
-0.19
49.28
6.77
6.88

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Shareholder's Funds
127.13
118.25
121.06
112.03
101.20
108.69
119.88
114.55
84.31
75.15
Share Capital
15.49
15.43
15.36
13.73
13.23
13.23
13.23
13.23
13.23
13.20
Total Reserves
111.28
101.63
104.58
94.56
86.59
94.08
105.27
99.94
69.20
59.88
Non-Current Liabilities
-0.90
-0.58
-0.62
-1.55
-2.47
-0.95
-0.51
0.82
0.89
38.48
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.04
0.00
42.99
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.00
Long Term Provisions
0.38
0.39
0.41
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
73.32
21.97
20.09
14.92
11.69
7.99
6.85
60.47
66.23
21.18
Trade Payables
53.65
7.10
4.35
7.72
5.68
3.69
2.39
3.66
10.25
11.83
Other Current Liabilities
1.41
1.22
3.89
3.50
3.22
3.35
3.92
1.33
38.00
2.16
Short Term Borrowings
14.80
12.61
9.45
0.92
0.69
0.19
0.00
8.77
15.63
0.00
Short Term Provisions
3.45
1.04
2.40
2.78
2.11
0.77
0.55
46.71
2.35
7.19
Total Liabilities
201.90
141.86
142.63
126.13
110.42
115.73
126.22
176.92
153.00
134.81
Net Block
29.96
31.53
32.13
32.96
33.31
42.41
9.38
8.64
41.93
44.26
Gross Block
71.01
70.59
69.19
67.97
66.28
65.62
22.55
20.78
74.27
70.99
Accumulated Depreciation
41.05
39.06
37.06
35.01
32.97
23.21
13.16
12.14
32.34
26.73
Non Current Assets
121.53
86.08
77.75
63.14
61.85
68.43
79.48
9.61
85.48
67.38
Capital Work in Progress
65.48
29.60
20.25
3.18
0.66
0.00
0.00
0.00
43.15
22.11
Non Current Investment
23.88
24.05
25.02
26.00
27.01
25.82
47.16
0.72
0.22
1.02
Long Term Loans & Adv.
0.44
0.36
0.34
0.22
0.08
0.20
22.94
0.25
0.19
0.00
Other Non Current Assets
1.76
0.54
0.00
0.79
0.79
0.00
0.00
0.00
0.00
0.00
Current Assets
80.36
55.79
64.88
62.98
48.57
47.27
46.72
167.31
67.51
67.08
Current Investments
36.40
27.81
28.42
30.29
26.02
23.12
24.67
137.59
0.00
0.00
Inventories
3.59
5.56
4.72
2.80
2.60
2.62
2.38
2.30
17.02
12.45
Sundry Debtors
22.92
15.86
19.44
20.69
14.61
16.37
12.62
15.03
38.70
47.92
Cash & Bank
12.50
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49
3.95
Other Current Assets
4.96
0.04
0.16
0.36
3.05
2.41
2.07
0.73
2.30
2.76
Short Term Loans & Adv.
4.91
3.73
4.21
4.07
2.98
2.38
2.00
0.22
1.30
2.71
Net Current Assets
7.05
33.81
44.78
48.07
36.87
39.28
39.87
106.84
1.28
45.90
Total Assets
201.89
141.87
142.63
126.12
110.42
115.73
126.23
176.92
152.99
134.82

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
45.66
4.46
0.29
1.42
1.12
17.23
-7.62
-29.35
22.08
12.04
PBT
5.12
1.61
8.59
6.11
-9.32
-11.63
-0.95
-9.69
13.12
13.55
Adjustment
2.80
-1.23
1.87
2.03
11.49
9.17
2.08
7.15
9.14
6.69
Changes in Working Capital
38.75
6.33
-5.99
-6.70
-1.08
19.71
-8.70
-26.81
-0.17
-5.01
Cash after chg. in Working capital
46.67
6.71
4.47
1.44
1.09
17.25
-7.56
-29.35
22.08
15.24
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-1.01
-2.25
-4.18
-0.02
0.03
-0.02
-0.06
0.00
0.00
-3.20
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-37.57
-10.45
-13.98
-4.45
-1.53
-19.57
-31.20
41.02
-23.87
-20.42
Net Fixed Assets
-0.42
-1.00
-1.67
-0.87
-0.66
-0.56
-2.00
96.84
-24.29
Net Investments
-8.42
1.58
0.88
-4.21
-4.10
-20.40
68.35
-138.00
-0.71
Others
-28.73
-11.03
-13.19
0.63
3.23
1.39
-97.55
82.18
1.13
Cash from Financing Activity
1.61
0.85
16.86
5.51
-0.04
0.11
-0.06
-9.49
7.33
7.31
Net Cash Inflow / Outflow
9.70
-5.14
3.17
2.48
-0.45
-2.23
-38.87
2.18
5.54
-1.07
Opening Cash & Equivalents
2.80
7.94
4.77
2.29
2.75
4.98
43.85
9.49
3.95
5.03
Closing Cash & Equivalent
12.50
2.80
7.94
4.77
2.29
2.75
4.98
11.67
9.49
3.95

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
81.82
75.85
78.11
78.86
75.44
81.07
89.54
85.53
62.30
55.09
ROA
2.19%
0.59%
2.85%
4.36%
-7.86%
-9.25%
-0.19%
46.26%
7.29%
7.96%
ROE
3.09%
0.71%
3.36%
4.95%
-8.59%
-9.91%
-0.25%
78.03%
13.52%
14.76%
ROCE
4.40%
1.95%
7.59%
6.08%
-8.69%
-10.11%
-0.74%
76.95%
13.06%
15.35%
Fixed Asset Turnover
0.97
0.76
1.20
0.76
0.44
0.48
0.88
2.33
2.05
2.01
Receivable days
103.03
120.72
88.79
125.86
197.00
252.10
265.25
88.74
106.38
122.60
Inventory Days
24.29
35.14
16.62
19.22
33.17
43.50
44.88
31.91
36.20
31.85
Payable days
297.22
42.27
32.14
59.43
52.58
37.09
69.84
26.25
31.47
35.31
Cash Conversion Cycle
-169.89
113.59
73.27
85.65
177.59
258.51
240.30
94.40
111.12
119.14
Total Debt/Equity
0.12
0.11
0.08
0.01
0.01
0.00
0.00
0.08
0.64
0.59
Interest Cover
6.84
2.71
14.25
15.68
-58.98
-183.29
-17.71
33.88
4.71
3.99

Top Investors:

dipak kanayalal shah
iepf

Annual Reports:

FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011

News Update:


  • Kilitch Drugs acquires land to establish green field pharma complex
    3rd Mar 2022, 17:29 PM

    The company plan to setup 4-6 manufacturing units in different therapeutics categories to cater to the growing demands Nationally and Internationally

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.